Back to search
DS Stage I Plasma Cell Myeloma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which DS Stage I Plasma Cell Myeloma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which DS Stage I Plasma Cell Myeloma trials you may qualify forThis phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (da…
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing s…
This randomized phase III trial studies lenalidomide to see how well it works compared to a placebo in treating patients with multiple myeloma who are undergoin…
This partially randomized phase I/II trial studies the side effects and best dose of elotuzumab and to see how well it works when given together with lenalidomi…